Skip to main content
. 2020 Mar 16;2020(3):CD011154. doi: 10.1002/14651858.CD011154.pub2

14.6. Analysis.

14.6

Comparison 14 BPO/clindamycin versus placebo or no treatment, Outcome 6 Investigator‐assessed percentage change in inflammatory lesions (long‐term data).